SUBCORTICAL EXCITATORY AMINO-ACID LEVELS AFTER ACUTE AND SUBCHRONIC ADMINISTRATION OF TYPICAL AND ATYPICAL NEUROLEPTICS

被引:35
作者
BARDGETT, ME
WRONA, CT
NEWCOMER, JW
CSERNANSKY, JG
机构
[1] Washington University School of Medicine, Department of Psychiatry, St. Louis
关键词
GLUTAMATE; DOPAMINE; NEUROLEPTICS; NUCLEUS ACCUMBENS; CORPUS STRIATUM; (RAT);
D O I
10.1016/0014-2999(93)90557-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of three atypical neuroleptic compounds, clozapine, sulpiride, and (-)-3-(3-hydroxyphenyl)-N-n-propyl-piperidine ((-)-3-PPP) were compared to the effects of haloperidol and saline on excitatory amino acid levels in the rodent nucleus accumbens and corpus striatum after acute (I day) and subchronic (28 days) treatment. Equivalent doses of each drug were determined by assessing their in vivo displacement of [H-3]spiperone binding in the nucleus accumbens and corpus striatum. After acute treatment, all three atypical neuroleptics, but not haloperidol, produced a significant decrease in nucleus accumbens glutamate concentrations. Acute haloperidol treatment significantly elevated glutamate concentrations in the corpus striatum when compared to all three atypical drugs. After subchronic treatment, (-)-3-PPP significantly increased glutamate concentrations in the nucleus accumbens when compared to the effects of haloperidol and clozapine. There were no major between-group differences in glutamate levels after subchronic treatment in the corpUS striatum. The effects of acute and subchronic neuroleptic administration on aspartate levels in the nucleus accumbens and corpus striatum were highly variable. These findings indicate that atypical and typical neuroleptics may alter subcortical excitatory amino acid levels in a site-specific manner.
引用
收藏
页码:245 / 250
页数:6
相关论文
共 37 条
[11]  
KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789
[12]  
KERKERIAN L, 1988, EXP BRAIN RES, V69, P424
[13]   MODULATORY EFFECT OF DOPAMINE ON HIGH-AFFINITY GLUTAMATE UPTAKE IN THE RAT STRIATUM [J].
KERKERIAN, L ;
DUSTICIER, N ;
NIEOULLON, A .
JOURNAL OF NEUROCHEMISTRY, 1987, 48 (04) :1301-1306
[14]   CLASSIFICATION OF NEUROLEPTIC DRUGS ACCORDING TO THEIR ABILITY TO INHIBIT APOMORPHINE-INDUCED LOCOMOTION AND GNAWING - EVIDENCE FOR 2 DIFFERENT MECHANISMS OF ACTION [J].
LJUNGBERG, T ;
UNGERSTEDT, U .
PSYCHOPHARMACOLOGY, 1978, 56 (03) :239-247
[15]  
MAURA G, 1989, J PHARMACOL EXP THER, V251, P1142
[16]   GLUTAMATERGIC CORTICOSTRIATAL PATH [J].
MCGEER, PL ;
MCGEER, EG ;
SCHERER, U ;
SINGH, K .
BRAIN RESEARCH, 1977, 128 (02) :369-373
[17]   DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA - REVIEW [J].
MELTZER, HY ;
STAHL, SM .
SCHIZOPHRENIA BULLETIN, 1976, 2 (01) :19-76
[19]   MODULATION OF STRIATAL [GLUTAMIC-H-3 ACID RELEASE BY DOPAMINERGIC DRUGS [J].
MITCHELL, PR ;
DOGGETT, NS .
LIFE SCIENCES, 1980, 26 (24) :2073-2081
[20]   SYSTEMATIC STUDY OF THE PHARMACOLOGICAL ACTIVITIES OF DOPAMINE ANTAGONISTS [J].
NIEMEGEERS, CJE ;
JANSSEN, PAJ .
LIFE SCIENCES, 1979, 24 (24) :2201-2216